Your browser doesn't support javascript.
loading
Improved Survival of HER2+ Breast Cancer Patients Treated with Trastuzumab and Chemotherapy Is Associated with Host Antibody Immunity against the HER2 Intracellular Domain.
Knutson, Keith L; Clynes, Raphael; Shreeder, Barath; Yeramian, Patrick; Kemp, Kathleen P; Ballman, Karla; Tenner, Kathleen S; Erskine, Courtney L; Norton, Nadine; Northfelt, Donald; Tan, Winston; Calfa, Carmen; Pegram, Mark; Mittendorf, Elizabeth A; Perez, Edith A.
Afiliação
  • Knutson KL; Department of Immunology, Mayo Clinic, Jacksonville, Florida. knutson.keith@mayo.edu.
  • Clynes R; Division of Hematology and Oncology, Columbia University, New York, New York.
  • Shreeder B; Department of Immunology, Mayo Clinic, Jacksonville, Florida.
  • Yeramian P; Cancer Vaccines and Immune Therapies Program, Center for Diseases of Aging, Vaccine and Gene Therapy Institute of Florida, Port St. Lucie, Florida.
  • Kemp KP; Cancer Vaccines and Immune Therapies Program, Center for Diseases of Aging, Vaccine and Gene Therapy Institute of Florida, Port St. Lucie, Florida.
  • Ballman K; Department of Health Sciences Research, Mayo Clinic, Rochester, Minnesota.
  • Tenner KS; Department of Health Sciences Research, Mayo Clinic, Rochester, Minnesota.
  • Erskine CL; Department of Immunology, Mayo Clinic, Rochester, Minnesota.
  • Norton N; Department of Cancer Biology, Mayo Clinic, Jacksonville, Florida.
  • Northfelt D; Division of Hematology and Oncology, Mayo Clinic, Scottsdale, Arizona.
  • Tan W; Division of Hematology and Oncology, Mayo Clinic, Jacksonville, Florida.
  • Calfa C; Memorial Hospital, Hollywood, Florida.
  • Pegram M; Stanford University, Stanford, California.
  • Mittendorf EA; Department of Surgical Oncology, The University of Texas MD Anderson Cancer Center, Houston, Texas.
  • Perez EA; Division of Hematology and Oncology, Mayo Clinic, Jacksonville, Florida.
Cancer Res ; 76(13): 3702-10, 2016 07 01.
Article em En | MEDLINE | ID: mdl-27197192
Assuntos
Texto completo
Imprimir
XML
PubMed Links
Buscar no Google

Texto completo: 1 Coleções: 01-internacional Contexto em Saúde: 2_ODS3 / 6_ODS3_enfermedades_notrasmisibles Base de dados: MEDLINE Assunto principal: Neoplasias da Mama / Protocolos de Quimioterapia Combinada Antineoplásica / Biomarcadores Tumorais / Receptor ErbB-2 Tipo de estudo: Clinical_trials / Observational_studies / Prognostic_studies / Risk_factors_studies Limite: Female / Humans Idioma: En Revista: Cancer Res Ano de publicação: 2016 Tipo de documento: Article
Texto completo
Imprimir
XML
PubMed Links
Buscar no Google

Texto completo: 1 Coleções: 01-internacional Contexto em Saúde: 2_ODS3 / 6_ODS3_enfermedades_notrasmisibles Base de dados: MEDLINE Assunto principal: Neoplasias da Mama / Protocolos de Quimioterapia Combinada Antineoplásica / Biomarcadores Tumorais / Receptor ErbB-2 Tipo de estudo: Clinical_trials / Observational_studies / Prognostic_studies / Risk_factors_studies Limite: Female / Humans Idioma: En Revista: Cancer Res Ano de publicação: 2016 Tipo de documento: Article